CDC45L-PEPTIDE UND IMPFSTOFFE DAMIT

Patent europeic · EP3556857 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3556857
Numer da la dumonda
EP19175920
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-05-2010
Publitgà
23-10-2019
Concedì
05-05-2021
Stritgà
23-12-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 15/09 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
C07K 14/47 (2006.01)
C07K 16/18 (2006.01)
C12N 5/078 (2010.01)
C12N 5/0783 (2010.01)
C12N 5/10 (2006.01)
Prioritad
US 21713309 P 26.05.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.12.2023

  2. 16-03-2022

    Midada

    Published in Swissreg on 16.03.2022

  3. 05-05-2021

    Concedì

    Published in Swissreg on 05.05.2021

Partidas

Possessur

OncoTherapy Science, Inc.

Oncotherapy Science, Inc.

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Inventur

NAKAMURA Yusuke

Bunkyo-ku, Tokyo 1138654, JP

NISHIMURA Yasuharu

Kumamoto-shi, Kumamoto 8608556, JP

TOMITA Yusuke

Kumamoto-shi, Kumamoto 8608556, JP

TSUNODA Takuya

Kawasaki-shi, Kanagawa 2130012, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.